Other
Share Repurchase Program, Remaining Authorized, Amount
Amgen Share Repurchase Program, Remaining Authorized, Amount remained flat by 0.0% to $6.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $6.80B to $6.80B. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
How to read this metric
A high remaining balance indicates potential future support for the stock price through buybacks.
Detailed definition
This is the portion of the board-authorized share repurchase program that has not yet been executed. It indicates the re...
Peer comparison
Used by investors to gauge the near-term potential for share count reduction and capital return.
Metric ID:
other_stock_repurchase_program_remaining_authorized_repu_889179Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.90B | $2.90B | $4.60B | $4.60B | $4.60B | $7.00B | $7.00B | $7.00B | $7.00B | $7.00B | $7.00B | $6.80B | $6.80B | $6.80B | $6.80B |
| QoQ Change | — | -25.6% | +58.6% | +0.0% | +0.0% | +52.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -2.9% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +17.9% | +58.6% | +52.2% | +52.2% | +52.2% | +0.0% | +0.0% | +0.0% | -2.9% | -2.9% | -2.9% | +0.0% |
Range$2.90B – $7.00B
CAGR+17.2%
Avg YoY Growth+18.7%
Median YoY Growth+0.0%
Current Streak3 quarters growth
Share Repurchase Program, Remaining Authorized, Amount at Other Companies
Frequently Asked Questions
- What is Amgen's share repurchase program, remaining authorized, amount?
- Amgen (AMGN) reported share repurchase program, remaining authorized, amount of $6.80B in Q1 2026.
- How has Amgen's share repurchase program, remaining authorized, amount changed year-over-year?
- Amgen's share repurchase program, remaining authorized, amount decreased by 0.0% year-over-year, from $6.80B to $6.80B.
- What does share repurchase program, remaining authorized, amount mean?
- The dollar amount of the share repurchase program that is still available to be used.